Filter Results:
(333)
Show Results For
- All HBS Web (333)
- Faculty Publications (142)
Show Results For
- All HBS Web (333)
- Faculty Publications (142)
- 01 Mar 2010
- News
Noted & Quoted
“Unfortunately, the technology for growing flu viruses to make vaccines is fifty years old — it’s chicken eggs.” — HBS Professor of Management Practice and former Merck CEO Raymond Gilmartin, at a November HBS panel discussion on drug... View Details
- 10 Oct 2017
- First Look
First Look at New Research and Ideas, October 10, 2017
watch a series of real, crime-related videos (while the control group watches non-crime-related videos). Not previously victimized participants exposed to the treatment video show significant changes in cortisol level, heart rate, and... View Details
Keywords: Sean Silverthorne
- 01 Mar 2006
- News
Using IT to Heal U.S. Health Care
health information network are expected to be substantial. A RAND Corporation study estimates savings to the U.S. health-care system of up to $162 billion a year by improving medical-care delivery, reducing medical errors and adverse drug... View Details
- 27 Feb 2024
- Blog Post
Fighting Cancer with a Novel Cell Therapy: Ananya Zutshi (MS/MBA '21)
and will call myself an engineer forever. But I recognized that my strengths and experiences are well suited for the business side of drug development.” Guardian Bio’s cell therapy uses dendritic cells, an essential component in the human... View Details
- 03 Jul 2012
- Research & Ideas
HBS Faculty on Supreme Court Health Care Ruling
invasive surgery, radiation, and chemotherapy for cancer, for example) with drugs that can palliate and perhaps cure genetically-linked diseases. But like most new technologies, these are hugely expensive to develop, and initially, to... View Details
- 02 Jan 2020
- Op-Ed
Medicare for All or Public Option: Can Either Heal Health Care?
for All published by the Harvard Business Review. [Image: Hispanolistic] Related Reading Germany May Have the Answer for Reducing Drug Prices What Hospitals Must Learn to Compete Making Health Insurance That Consumers Actually Like What... View Details
- 05 May 2020
- News
“Walking a Tightrope”
is going to be transmitted yet again to the next generation. A year and a half, two years ago now, we ran into Drew. He was in a drug treatment program called Provoking Hope based in McMinnville, Oregon.... View Details
- 01 Jun 2015
- News
Rebooting Europe
targeted effort to improve Ebola treatments resulted in development of an antiviral drug with potential to treat the early stages of the disease. Better research, Moedas says, also requires better support... View Details
- 02 Aug 2004
- Research & Ideas
Health Care Research and Prospects
series on AIDS in Africa and how pharmaceutical companies should think about the issues and how they might respond. Sandra Sucher has done a really wonderful case on Gleevec, which is a drug for treating chronic myeloid leukemia. She is... View Details
- 01 Jun 2011
- News
The Best-Laid Plans
in on a treatment for age-related macular degeneration, a leading cause of blindness. In October 2009 the company entered into licensing and purchase option agreements with Alcon, which is now taking Potentia’s View Details
- 08 Aug 2011
- Research & Ideas
The Death of the Global Manager
and its efforts to establish Humanitarian Assistance for Neglected Diseases (HAND), a corporate social responsibility program focused on treatments for diseases that typically affect too small a population to warrant the attention of... View Details
Keywords: by Julia Hanna
- 06 Apr 2015
- Research & Ideas
After Germanwings, More Attention Needed on Employee Mental Health
people? One possible answer came this past week when the airline revealed that the pilot, Andreas Lubitz, had previously suffered from deep depression. Debates began about how Lubitz's mental health played into the tragedy, what treatment... View Details
- 01 Sep 2006
- News
Redefining Health Care
high costs understandable. What Wennberg and others did was to show that U.S. health care also has severe quality problems. Indeed, there is every possible quality problem you can imagine: incorrect diagnoses, drug errors, unnecessary... View Details
- 01 Dec 2002
- News
Alumni Honorees Urge Students to Emphasize Ethics
2002 Alumni Achievement Awards Raymond V. Gilmartin (MBA '68) Chairman, President, and CEO, Merck & Co. Since June 1994, when Gilmartin became its president and CEO, Merck has launched seventeen new drugs and increased revenues from $15... View Details
- 14 Jul 2006
- Op-Ed
The Case for Consumer-Driven Medicaid
diabetic and asthmatic enrollees due to increased testing and drug utilization, while management consulting firm McKinsey found that consumer-driven enrollees were more likely to "very carefully follow View Details
Keywords: by Regina E. Herzlinger
- 13 Jul 2009
- Research & Ideas
Diagnosing the Public Health Care Alternative
of its inadequate payments. In the end, the Democrats' health care reform will require drastic rationing of health care for the sick to control its costs. The government-controlled UK health care system points the way because it features, for example, the lowest uptake... View Details
- 01 Dec 2018
- News
Case Study: Your Data, Your Health
the cost of paying for health insurance subscribers, which will bring higher returns for the insurance company. We have seen this in the drug Angiomax by the Medicines Company. —Suleiman Yakasai (PLDA 22, 2016) Got a case? To take part in... View Details
Keywords: Jen McFarland Flint
- 03 Mar 2017
- News
Big Blue’s Big Bet
conclusion by manually going through the data,” the lead doctor told the Japan Times, “but Watson’s speed is crucial in the treatment of leukemia, which progresses rapidly and can cause complications.” This is the beauty of Watson, which... View Details
Keywords: Paul Kix; illustrations by Dan Page
- 04 Nov 2016
- News
The Competitiveness of Lost Causes
regulations, in part by helping producers secure public guarantees for financing a $17 million water treatment plant. “That was a success story that saved and created jobs and became the basis of an HBS case,” notes Duch. “Today everyone... View Details
Keywords: Deborah Blagg
- 28 Jul 2015
- First Look
First Look: July 28, 2015
of Dublin, Ireland-based Elan Drug Technologies (EDT)-a deal that was expected to close in the fall. The case describes the history of Alkermes, provides information about the planned merger, and details the funding options. The case... View Details
Keywords: Carmen Nobel